EMORY UNIVERSITY
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1836-12-10
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.emory.edu
Tacrolimus, Bortezomib, & Thymoglobulin in Preventing Low Toxicity GVHD in Donor Blood Stem Cell Transplant Patients
Phase 2
Terminated
- Conditions
- Acute LeukemiaChronic Myelogenous Leukemia, BCR-ABL1 PositiveFollicular LymphomaMarginal Zone LymphomaChronic Lymphocytic LeukemiaGraft Versus Host DiseaseMyelofibrosisSmall Lymphocytic LymphomaDiffuse Large B-Cell LymphomaMantle Cell Lymphoma
- Interventions
- First Posted Date
- 2016-08-24
- Last Posted Date
- 2018-04-30
- Lead Sponsor
- Emory University
- Target Recruit Count
- 5
- Registration Number
- NCT02877082
- Locations
- 🇺🇸
Emory University/Winship Cancer Institute, Atlanta, Georgia, United States
The Immunologic Basis for an Attenuated Immune Response to the Influenza Vaccine After Repeated Annual Vaccination
Phase 4
Completed
- Conditions
- Influenza
- Interventions
- Biological: 2016-2017 Influenza Vaccine
- First Posted Date
- 2016-08-23
- Last Posted Date
- 2018-12-12
- Lead Sponsor
- Emory University
- Target Recruit Count
- 20
- Registration Number
- NCT02876159
- Locations
- 🇺🇸
The Hope Clinic of the Emory Vaccine Center, Atlanta, Georgia, United States
New Strategies to Assess Anal Cancer Risk In Women
Completed
- Conditions
- Human Immunodeficiency Virus (HIV)Human Papillomavirus (HPV)
- Interventions
- Procedure: Perianal and Digital Anorectal ExamProcedure: Cervical SwabsProcedure: Anal SwabsProcedure: High Resolution Anoscopy (HRA)
- First Posted Date
- 2016-08-19
- Last Posted Date
- 2019-11-06
- Lead Sponsor
- Emory University
- Target Recruit Count
- 143
- Registration Number
- NCT02873741
- Locations
- 🇺🇸
The Ponce Center, Atlanta, Georgia, United States
Pembrolizumab and Stereotactic Radiosurgery for Melanoma or Non-Small Cell Lung Cancer Brain Metastases
Phase 1
Completed
- Conditions
- Stage IV Skin MelanomaMelanoma of Unknown PrimaryMetastatic Malignant Neoplasm in the BrainMetastatic MelanomaMucosal MelanomaOcular MelanomaStage IV Non-Small Cell Lung Cancer
- Interventions
- Biological: PembrolizumabRadiation: Stereotactic Radiosurgery
- First Posted Date
- 2016-08-08
- Last Posted Date
- 2024-05-13
- Lead Sponsor
- Emory University
- Target Recruit Count
- 27
- Registration Number
- NCT02858869
- Locations
- 🇺🇸
Emory University/Winship Cancer Institute, Atlanta, Georgia, United States
Tailoring of Vaccine-Focused Messages: Moral Foundations
Not Applicable
Completed
- Conditions
- Childhood Vaccinations
- Interventions
- Behavioral: Baseline SurveyBehavioral: Pre-intervention SurveyBehavioral: Morally Congruent MessageBehavioral: Morally Non-Congruent MessageBehavioral: Control MessageBehavioral: Post-Intervention Survey
- First Posted Date
- 2016-08-01
- Last Posted Date
- 2017-03-10
- Lead Sponsor
- Emory University
- Target Recruit Count
- 850
- Registration Number
- NCT02851459
- Locations
- 🇺🇸
Emory University School Of Public Health - Only Online Recruitment, Atlanta, Georgia, United States
STRIDE Biorepository
- Conditions
- Anemia, Sickle Cell
- Interventions
- Procedure: Blood draw
- First Posted Date
- 2016-07-25
- Last Posted Date
- 2021-02-08
- Lead Sponsor
- Emory University
- Target Recruit Count
- 200
- Registration Number
- NCT02843347
- Locations
- 🇺🇸
Children's National Medical Center, Washington, District of Columbia, United States
🇺🇸University of Florida Gainsville, Gainesville, Florida, United States
🇺🇸Benioff Children's Hospital at Oakland, Oakland, California, United States
Employing End Tidal Capnography in Continuous Flow Ventricular Assist Device Patients
Not Applicable
Withdrawn
- Conditions
- CardiomyopathyHeart DiseaseCardiovascular Disease
- Interventions
- Device: Respiratory Depression Monitoring with End Tidal Carbon Dioxide Nasal Cannula (ETCO2- NC)Other: Standard Non-invasive Respiratory Depression Monitoring
- First Posted Date
- 2016-07-20
- Last Posted Date
- 2018-03-20
- Lead Sponsor
- Emory University
- Registration Number
- NCT02838355
- Locations
- 🇺🇸
Emory University Hospital, Atlanta, Georgia, United States
Fitbit for Postoperative Ambulation
Not Applicable
Completed
- Conditions
- Postoperative Care
- Interventions
- Behavioral: Education regarding ambulationBehavioral: Ambulation reminder alarmsOther: Fitbit
- First Posted Date
- 2016-07-14
- Last Posted Date
- 2017-10-17
- Lead Sponsor
- Emory University
- Target Recruit Count
- 48
- Registration Number
- NCT02833324
- Locations
- 🇺🇸
Emory University Hospital, Atlanta, Georgia, United States
FACBC Prostate Therapy Response
Phase 2
Completed
- Conditions
- Prostate Cancer
- Interventions
- Drug: FACBC PET-CTOther: MRI, CT, or Bone Scan
- First Posted Date
- 2016-07-13
- Last Posted Date
- 2020-01-07
- Lead Sponsor
- Emory University
- Target Recruit Count
- 7
- Registration Number
- NCT02830880
- Locations
- 🇺🇸
Emory University Hospital, Atlanta, Georgia, United States
Worksite Lifestyle Program for Reducing Diabetes and Cardiovascular Risk in India
Not Applicable
Completed
- Conditions
- DiabetesObesityHeart Disease
- Interventions
- Behavioral: Lifestyle Intervention Training Program
- First Posted Date
- 2016-06-27
- Last Posted Date
- 2023-09-21
- Lead Sponsor
- Emory University
- Target Recruit Count
- 2108
- Registration Number
- NCT02813668
- Locations
- 🇮🇳
Madras Diabetes Research Foundation, Chennai, India
🇮🇳Public Health Foundation of India, New Delhi, India
© Copyright 2025. All Rights Reserved by MedPath